Heparin can be a good option for thromboprophylaxis, except in patients with antithrombin III (AT-III) deficiency, who use direct thrombin inhibitors, such as argatroban, which can be a better choice for systemic anticoagulation [33]. This evidence concerns the gene SERPINC1 and hereditary antithrombin deficiency.